Christopher Flint OBrien, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 25,000 shares at $52.84 ($1.3M) on 2016-11-15, disclosed to the SEC on 2016-11-16.
Open-market sale of $1.3M NBIX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NBIX | SELL | 2017-11-06 | $7.4M | — | Filing → |
| NBIX | SELL | 2017-10-03 | $423K | — | Filing → |
| NBIX | SELL | 2017-09-07 | $6.1M | — | Filing → |